![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NOSIP |
Gene summary for NOSIP |
![]() |
Gene information | Species | Human | Gene symbol | NOSIP | Gene ID | 51070 |
Gene name | nitric oxide synthase interacting protein | |
Gene Alias | CGI-25 | |
Cytomap | 19q13.33 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | Q9Y314 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51070 | NOSIP | S028 | Human | Liver | HCC | 7.98e-18 | 1.01e+00 | 0.2503 |
51070 | NOSIP | S029 | Human | Liver | HCC | 2.90e-22 | 1.18e+00 | 0.2581 |
51070 | NOSIP | C04 | Human | Oral cavity | OSCC | 1.20e-35 | 1.94e+00 | 0.2633 |
51070 | NOSIP | C21 | Human | Oral cavity | OSCC | 6.82e-63 | 1.77e+00 | 0.2678 |
51070 | NOSIP | C30 | Human | Oral cavity | OSCC | 4.61e-43 | 2.26e+00 | 0.3055 |
51070 | NOSIP | C38 | Human | Oral cavity | OSCC | 2.46e-19 | 1.96e+00 | 0.172 |
51070 | NOSIP | C43 | Human | Oral cavity | OSCC | 1.12e-84 | 1.45e+00 | 0.1704 |
51070 | NOSIP | C46 | Human | Oral cavity | OSCC | 2.25e-46 | 1.17e+00 | 0.1673 |
51070 | NOSIP | C51 | Human | Oral cavity | OSCC | 6.99e-21 | 1.17e+00 | 0.2674 |
51070 | NOSIP | C57 | Human | Oral cavity | OSCC | 1.89e-32 | 1.06e+00 | 0.1679 |
51070 | NOSIP | C06 | Human | Oral cavity | OSCC | 1.54e-12 | 2.04e+00 | 0.2699 |
51070 | NOSIP | C07 | Human | Oral cavity | OSCC | 8.54e-06 | 1.40e+00 | 0.2491 |
51070 | NOSIP | C08 | Human | Oral cavity | OSCC | 2.48e-55 | 1.08e+00 | 0.1919 |
51070 | NOSIP | C09 | Human | Oral cavity | OSCC | 2.30e-08 | 4.01e-01 | 0.1431 |
51070 | NOSIP | LN22 | Human | Oral cavity | OSCC | 1.70e-07 | 9.84e-01 | 0.1733 |
51070 | NOSIP | LN38 | Human | Oral cavity | OSCC | 3.27e-07 | 1.43e+00 | 0.168 |
51070 | NOSIP | LN46 | Human | Oral cavity | OSCC | 2.31e-30 | 1.28e+00 | 0.1666 |
51070 | NOSIP | LP15 | Human | Oral cavity | LP | 8.27e-06 | 1.18e+00 | 0.2174 |
51070 | NOSIP | LP16 | Human | Oral cavity | LP | 8.52e-03 | 8.58e-01 | 0.1055 |
51070 | NOSIP | LP17 | Human | Oral cavity | LP | 1.67e-03 | 1.04e+00 | 0.2349 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0051341 | Colorectum | SER | regulation of oxidoreductase activity | 27/2897 | 107/18723 | 5.86e-03 | 4.29e-02 | 27 |
GO:00509991 | Thyroid | PTC | regulation of nitric-oxide synthase activity | 22/5968 | 44/18723 | 9.27e-03 | 3.82e-02 | 22 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NOSIP | SNV | Missense_Mutation | c.299N>C | p.Lys100Thr | p.K100T | Q9Y314 | protein_coding | tolerated(0.31) | benign(0.003) | TCGA-EW-A1OZ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Targeted Molecular therapy | trastuzumab | SD | |
NOSIP | deletion | In_Frame_Del | novel | c.114_131delTGCCGTGAAGGACTTCGA | p.Ala39_Asp44del | p.A39_D44del | Q9Y314 | protein_coding | TCGA-EW-A3U0-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | CR | ||
NOSIP | SNV | Missense_Mutation | rs769816516 | c.334C>T | p.Arg112Trp | p.R112W | Q9Y314 | protein_coding | deleterious(0) | possibly_damaging(0.837) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
NOSIP | SNV | Missense_Mutation | c.394A>C | p.Lys132Gln | p.K132Q | Q9Y314 | protein_coding | tolerated(0.24) | benign(0.154) | TCGA-AA-A022-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NOSIP | SNV | Missense_Mutation | novel | c.887N>A | p.Arg296Gln | p.R296Q | Q9Y314 | protein_coding | deleterious(0.02) | probably_damaging(0.963) | TCGA-AM-5821-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NOSIP | SNV | Missense_Mutation | rs769816516 | c.334N>T | p.Arg112Trp | p.R112W | Q9Y314 | protein_coding | deleterious(0) | possibly_damaging(0.837) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
NOSIP | SNV | Missense_Mutation | rs376400410 | c.545N>T | p.Thr182Met | p.T182M | Q9Y314 | protein_coding | deleterious(0.03) | possibly_damaging(0.577) | TCGA-D5-6530-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NOSIP | SNV | Missense_Mutation | c.68N>T | p.Thr23Ile | p.T23I | Q9Y314 | protein_coding | deleterious(0.01) | probably_damaging(0.987) | TCGA-G4-6302-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NOSIP | SNV | Missense_Mutation | c.284N>A | p.Arg95Gln | p.R95Q | Q9Y314 | protein_coding | tolerated(0.39) | benign(0.001) | TCGA-EI-6510-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NOSIP | SNV | Missense_Mutation | rs767271460 | c.649N>T | p.Arg217Cys | p.R217C | Q9Y314 | protein_coding | deleterious(0) | probably_damaging(0.955) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |